Table 5.
Unadjusted and Adjusted Odds of Liver‐Related Mortality Among Intervention Patients Within 12 Months of Recruitment
| Clinical and Demographic Variables | Unadjusted | Adjusted | |||
|---|---|---|---|---|---|
| OR (95% CI) | P | aOR* (95% CI) | P | ||
| Age | 1.01 (0.94‐1.09) | 0.741 | 1.06 (0.96‐1.17) | 0.215 | |
| Sex | Male | 0.74 (0.16‐3.48) | 0.698 | 1.00 (0.11‐8.83) | 1.000 |
| Current alcohol consumption | 1.71 (0.29‐10.04) | 0.553 | 0.61 (0.04‐10.76) | 0.738 | |
| MELD score | 1.11 (0.97‐1.27) | 0.147 | 1.08 (0.91‐1.28) | 0.372 | |
| Child‐Pugh score | 1.52 (0.95‐2.41) | 0.079 | 1.36 (0.72‐2.58) | 0.350 | |
| Variceal bleeding (in the preceding 2 years) | 1.02 (0.11‐9.84) | 0.984 | 1.03 (0.04‐26.48) | 0.986 | |
| Hepatocellular carcinoma | 28.80 (2.50‐331.55) | 0.007 | 86.30 (4.79‐1.56 × 103) | 0.003 | |
| Number of medicines at baseline | Total | 1.26 (1.03‐1.53) | 0.026 | 1.27 (0.94‐1.70) | 0.116 |
| CLD | 2.06 (1.14‐3.71) | 0.016 | 2.01 (0.92‐4.38) | 0.081 | |
| Non‐CLD | 1.17 (0.96‐1.42) | 0.127 | 1.15 (0.87‐1.51) | 0.341 | |
| Number of high‐risk MRPs per contact | 2.46 (1.12‐5.38) | 0.025 | 3.84 (1.41‐10.50) | 0.009 | |
| Charlson Comorbidity Index | 1.47 (1.12‐1.94) | 0.006 | 1.25 (0.81‐1.93) | 0.309 | |
| Education | Nil to middle school | 6.60 (0.73‐59.68) | 0.093 | 3.56 (0.31‐41.03) | 0.309 |
| Living in “most disadvantaged” areas | 4.62 (0.96‐22.09) | 0.056 | 3.71 (0.51‐27.07) | 0.197 | |
| Living in “accessible” to “remote” areas | 7.83 (0.93‐66.33) | 0.059 | 10.45 (0.68‐161.51) | 0.093 | |
All patients who died were unemployed and on government welfare.
*Adjusted for number of high‐risk MRPs per contact and presence of hepatocellular carcinoma.